Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704652 | SCV000589898 | likely benign | not provided | 2021-02-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 24895405) |
Center for Genomics, |
RCV001027811 | SCV001190427 | likely benign | Brittle cornea syndrome 1 | 2019-10-22 | criteria provided, single submitter | clinical testing | ZNF469 NM_001127464.2 exon 2 p.Glu2509Asp (c.7527G>C): This variant has been reported in the literature in one individual with keratoconus (Lechner 2014 PMID:24895405). However, this variant is also present in 0.8% (145/16606) of African alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/16-88501489-G-C). This variant is present in ClinVar (Variation ID:432202). This variant amino acid Aspartic acid (Asp) is present in several species including multiple mammals, and it is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant suggests that this variant does not cause disease, but requires further evidence. Therefore this variant is classified as likely benign. |
Labcorp Genetics |
RCV001704652 | SCV002469685 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001027811 | SCV002514311 | benign | Brittle cornea syndrome 1 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002395203 | SCV002669127 | likely benign | Cardiovascular phenotype | 2019-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |